Establishing an integrated approach to head and neck cancer treatment and prevention: The Robert Ebert and Greg Stubblefield Head and Neck Tumor Center Model
Ryan S. Jackson(Washington University in St. Louis), Sara Kukuljan(Barnes-Jewish Hospital), Jason T. Rich(Washington University in St. Louis), Karolina A. Plonowska‐Hirschfeld(University of California, San Francisco), Adepitan A. Owosho(A.T. Still University), Nikhil Ram-Mohan(Stanford University), Sana D. Karam(University of Colorado Denver), John Lynch(University of Cincinnati), Jennifer C. Myers(Barnes-Jewish Hospital), Salma Ramadan(Washington University in St. Louis), R. Alex Harbison(Washington University in St. Louis), Courtney Wagner(Barnes-Jewish Hospital), Patrik Pipkorn(Washington University in St. Louis), Crystal Lee(Deakin University), Kelsey Rosenquist(Barnes-Jewish Hospital), Katherine E. Schwetye(Washington University in St. Louis), Michael J. Moravan(Duke Medical Center), Craig A. Buchman(Washington University in St. Louis), Douglas R. Adkins(Washington University in St. Louis), Michael P. Wu(Massachusetts Eye and Ear Infirmary), Tim Eberlein, Jennifer De Los Santos(University of Alabama at Birmingham), Kristin Daly(Washington University in St. Louis), Paul Zolkind(Washington University in St. Louis), Jesse M. Zaretsky(Washington University in St. Louis), Wade Thorstad(Jewish Hospital), Daniel Miller(New York State Department of Environmental Conservation), Kathryn Slane(Barnes-Jewish Hospital), Zach Cole(Barnes-Jewish Hospital), Ashley Jackson(Barnes-Jewish Hospital), Peter Oppelt(Washington University in St. Louis), Allison Ogden(Washington University in St. Louis), Shelby Britt(Barnes-Jewish Hospital), Tonya Wibbenmeyer(Barnes-Jewish Hospital), Sandra Dimitri(Barnes-Jewish Hospital), Kristin Schlueter(Barnes-Jewish Hospital), John Monterubio(Barnes-Jewish Hospital), Eugenio Herbosa(Barnes-Jewish Hospital), Nicholas Branham(Barnes-Jewish Hospital), Rebecca Grammer(Barnes-Jewish Hospital), T J Apicelli(Jewish Hospital), Jessica Ley(Washington University in St. Louis), Angeleen Peters-Lewis(Barnes-Jewish Hospital)
Cited by 1
Related Papers
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
|New England Journal of Medicine|2016|3.1k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
|The Lancet Oncology|2013|748
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018
|Journal of the National Comprehensive Cancer Network|2018|632